Park Avenue Securities LLC Neurocrine Biosciences Inc Transaction History

Park Avenue Securities LLC

$9.72 Billion
Q4 2024

A detailed history of Park Avenue Securities LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Park Avenue Securities LLC holds 7,080 shares of NBIX stock, worth $1.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,080

Previous 5,744 23.26%

Holding current value

$1.01 Million

Previous $662,000 45.92%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	BUY	$111.62 - $139.44 $149,124 - $186,291	1,336 Added 23.26%	7,080 $966,000
Q3 2024 Oct 03, 2024	SELL	$114.58 - $153.15 $479,975 - $641,545	-4,189 Reduced 42.17%	5,744 $662,000
Q2 2024 Jul 09, 2024	BUY	$130.86 - $143.19 $47,502 - $51,977	363 Added 3.79%	9,933 $1.37 Million
Q1 2024 Apr 10, 2024	BUY	$130.4 - $143.74 $13,170 - $14,517	101 Added 1.07%	9,570 $1.32 Million
Q4 2023 Jan 10, 2024	BUY	$106.07 - $132.76 $56,004 - $70,097	528 Added 5.91%	9,469 $1.25 Million
Q3 2023 Oct 26, 2023	BUY	$94.02 - $117.1 $840,632 - $1.05 Million	8,941 New	8,941 $1.01 Million
Q4 2022 Jan 24, 2023	BUY	$106.72 - $127.06 $3,308 - $3,938	31 Added 0.36%	8,553 $0
Q3 2022 Nov 01, 2022	SELL	$92.03 - $107.81 $64,052 - $75,035	-696 Reduced 7.55%	8,522 $905,000
Q2 2022 Jul 27, 2022	BUY	$75.79 - $100.07 $98,527 - $130,090	1,300 Added 16.42%	9,218 $899,000
Q1 2022 Apr 29, 2022	BUY	$72.45 - $94.81 $294,436 - $385,307	4,064 Added 105.45%	7,918 $742,000
Q4 2021 Apr 08, 2022	SELL	$79.65 - $106.22 $153,166 - $204,261	-1,923 Reduced 33.29%	3,854 $328,000
Q3 2021 Oct 21, 2021	BUY	$86.18 - $99.03 $48,519 - $55,753	563 Added 10.8%	5,777 $554,000
Q2 2021 Aug 05, 2021	BUY	$89.43 - $102.27 $101,592 - $116,178	1,136 Added 27.86%	5,214 $507,000
Q1 2021 Apr 28, 2021	BUY	$87.57 - $119.4 $59,985 - $81,789	685 Added 20.19%	4,078 $397,000
Q4 2020 Jan 20, 2021	BUY	$86.91 - $108.33 $27,550 - $34,340	317 Added 10.31%	3,393 $325,000
Q3 2020 Nov 03, 2020	BUY	$96.16 - $135.15 $112,026 - $157,449	1,165 Added 60.96%	3,076 $296,000
Q2 2020 Jul 30, 2020	BUY	$85.09 - $130.36 $162,606 - $249,117	1,911 New	1,911 $233,000

Others Institutions Holding NBIX

# of Institutions

632

Shares Held

93.9M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Neurocrine Biosciences Inc Transaction History